Navigation Links
Oral Cancer Foundation Praised for Its Social Media Efforts
Date:7/1/2009

Social Media Guru Mashable.com Cites Organizations Using Social Media for Public Good

NEWPORT BEACH, Calif., July 1 /PRNewswire-USNewswire/ -- The Oral Cancer Foundation was recently praised by a leading Internet media Web site in an article discussing non-profit organizations that are effectively using Internet-based social media for the public good. Mashable, the world's largest site focused exclusively on Web 2.0 and social media such as blogs, Facebook, YouTube and Twitter, touted the online efforts of several organizations in a recent story entitled, 5 Unique Social Good "Finds." Other organizations cited included The National Suicide Prevention Hotline and the ASPCA.

Founded in July 2005, Mashable is the most prolific source for information and reviews of new Web sites and services, publishes breaking news on new web developments, and provides social media resources and guides. Mashable's audience includes early adopters and influencers, social media enthusiasts, entrepreneurs, large and small corporations, marketing, PR and advertising agencies, Web 2.0 aficionados, and technology journalists.

"We are flattered that our social media efforts have generated the attention and kind words of such a leading edge organization," said Brian Hill, Founder and Executive Director of the Oral Cancer Foundation. "We dedicate a great deal of time and focus to social media, which we believe allows us to connect with younger members of our audience in a way that is richer, more meaningful, and more relevant than we can achieve using more traditional media. This is particularly important to us, as individuals impacted by oral cancers have been increasingly young people, previously not thought to be at risk. Learning from Mashable's expertise has helped us to reach out to this younger, technology savvy population, with information we hope will help them avoid risk factors for oral cancers, and underst
'/>"/>

SOURCE Oral Cancer Foundation
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Newly appreciated membrane estrogen receptor important therapeutic target for breast cancer
2. Cancer survivors at greater risk of birth complications; special monitoring needed
3. Calling All Runners: Join the Fight Against Cancer
4. Study identifies biomarker that safely monitors tumor response to new brain cancer treatment
5. Lung Cancer Alliance Releases Updated 2009 Facts About Lung Cancer
6. Metabolic factors may play a role in risk for breast cancer
7. Possible benefit from online genetic testing for lung cancer
8. Metabolic Syndrome May Make Breast Cancer More Likely
9. Save the ta-tas Calling on Women to Join the Love/Avon Army of Women to Unlock the Key to Breast Cancer Prevention
10. Damon Runyon Cancer Research Foundation awards $2.7M to 7 top young clinical investigators
11. Bladder Cancer No Longer a Death Sentence
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Americans United for Life Condemns Ruling Increasing Minors' Access to Dangerous Plan B 2Health News:AANS President to Testify on Patient Access to Care 2Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 2Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 3Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 4Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 5Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 6Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 7Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 8Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 9Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 10Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 11Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 12Health News:Young Survival Coalition and Living Beyond Breast Cancer Announce Support for Rep. Wasserman Schultz's 'The Early Act' 2Health News:Lowest Blood Pressure, Cholesterol Levels the Best 2Health News:Lowest Blood Pressure, Cholesterol Levels the Best 3
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 1Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 2Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 3Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 1Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 2Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 3SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 1SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 2SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 3